Camilla Foged

Camilla Foged

Professor


  1. Published

    A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4(+) T-cell response

    Karlsen, K., Korsholm, K. S., Mortensen, R., Ghiasi, Seyed Mojtaba, Andersen, P., Foged, Camilla & Christensen, D., Dec 2014, In: Nanomedicine. 9, 17, p. 2625-38 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522

    Rose, F., Erbo Wern, J., Gavins, F., Andersen, P., Follmann, F. & Foged, Camilla, Feb 2018, In: Journal of Controlled Release. 271, p. 88-97 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A synthetic mycobacterial monomycoloyl glycerol analogue stabilizes DDA liposomes

    Nordly, P. J., Pedersen, E. A., Khiljii, T. S., Agger, E. M., Jørgensen, Lene, Nielsen, Hanne Mørck, Korsholm, K. S., Franzyk, Henrik & Foged, Camilla, 2010, In: CRS Newsletter. 27, 2, p. 12 14 p.

    Research output: Contribution to journalJournal articleResearch

  4. Published

    ANTI-INFLAMMATORY EFFECT OF ANTI-TNF-ALPHA siRNA CATIONIC PHOSPHOROUS DENDRIMERS NANOCOMPLEXES ADMINISTERED INTRANASALLY IN A MURINE ACUTE LUNG INJURY MODEL

    Bohr, A., Tsapis, N., Andreana, I., Chamarat, A., Foged, Camilla, Delomenie, C., Noiray, M., El Brahmi, N., Majoral, J., Mignani, S. & Fattal, E., 21 Jun 2017, In: Biomacromolecules. 18, 8, p. 2379–2388

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Adjuvants based on synthetic mycobacterial cord factor analogues: Biophysical properties of neat glycolipids and nano-self-assemblies with DDA

    Kallerup, R. S., Franzyk, Henrik, Schiøth, M. L., Justesen, S., Martin-Bertelsen, Birte, Rose, F., Madsen, C. M., Christensen, D., Korsholm, K. S., Yaghmur, Anan & Foged, Camilla, 12 May 2017, In: Molecular Pharmaceutics. 14, 7, p. 2294-2306 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction

    Wørzner, K., Hvannastein, J., Tandrup Schmidt, S., Foged, Camilla, Rosenkrands, I., Kristian Pedersen, G. & Christensen, D., 2021, In: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 165, p. 293-305

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens

    Wu, L., Leng, D., Cun, D., Foged, Camilla & Yang, Mingshi, Aug 2017, In: Journal of Controlled Release. 260, p. 78-91

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Submitted
  9. Published

    Antiplasmodial and prehemolytic activities of alpha-peptide-beta-peptoid chimeras

    Vedel, L., Bonke, G., Foged, Camilla, Ziegler, H. L., Franzyk, Henrik, Jaroszewski, J. W. & Olsen, Christian Adam, 2007, In: ChemBioChem. 8, 15, p. 1781-1784 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Application of a Quality-By-Design Approach to Optimise Lipid-Polymer Hybrid Nanoparticles Loaded with a Splice-Correction Antisense Oligonucleotide: Maximising Loading and Intracellular Delivery

    Thanki, K., Papai, S., Lokras, Abhijeet Girish, Rose, F., Falkenberg, E., Franzyk, Henrik & Foged, Camilla, 2019, In: Pharmaceutical Research. 36, 3, 37.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next

ID: 1299454